Content
Cronos Q1 Financial Metrics Show Improvement; Stock Climbs 3%
Article By:
Lorimer Wilson
Read
Sunday, May 12, 2024 6:39 PM EDT
Cronos Group's stock price was up 25.4% in Q1 (January, February, March), rose 8.8% between then and the release of the Q1 report on May 9th, before slipping by 2.8% the following day. The stock is now up 32.5% YTD.
In this article: CRON
Taboola Q1 2024 Results Beat High End Of Guidance; Reiterates 2024 Guidance And Expects Accelerating Growth Across All Key Metrics
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, May 8, 2024 6:31 AM EDT
Taboola (Nasdaq: TBLA), a market leading technology company powering recommendations for the open web, today announced its results for the quarter ended March 31, 2024.
In this article: TBLA
Berkshire Hathaway Inc. First Quarter 2024 Earnings Release
Article By:
Business Wire
Read
Saturday, May 4, 2024 9:23 AM EDT
Berkshire Hathaway and its subsidiaries engage in diverse business activities including insurance and reinsurance, freight rail transportation, utilities & energy, manufacturing services & retailing. Their common stock is listed on the NYSE.
Acquisitional Wealth: A Game-Changer For Financial Freedom
Article By:
Fred Fuld III
Read
Monday, April 1, 2024 2:47 AM EDT
This book is more than just strategies. It’s about challenging limiting beliefs and approaching wealth-building with a new perspective.
Ethereum Crypto Price News Today - Elliottwave Technical Analysis
Article By:
Peter Mathers
Read
Sunday, March 24, 2024 9:03 PM EDT
Ethereum as a whole is moving in an uptrend with an Impulse pattern where the third wave of the move is now complete. We are currently recovering in the short term from the fourth wave correction.
In this article: ETH-X
CERo Therapeutics, Inc. Announces Publication Of Preclinical Research Supporting The Use Of Its Clinical Candidate CER-1236 To Treat AML Patients
Article By:
Business Wire
Read
Thursday, March 7, 2024 7:00 AM EDT
The paper details preclinical studies by CERo analyzing its lead clinical candidate CER-1236 in targeting Acute Myelogenous Leukemia (AML) tumor cells from human patients, and the candidate’s killing effects on these tumor cells.
Yum China Rebounds In 2023 With Record Levels Of Revenue Of Store Expansion
Article By:
Cents For Sense
Read
Saturday, February 10, 2024 3:36 PM EDT
Yum China accelerated its expansion and delivered impressive financial results for the year. The company’s robust business model and adaptability have continued to underpin its strong performance.
In this article: YUM
FRO – Sale Of Its Five Oldest VLCCs
Article By:
NASDAQ GlobeNewswire
Read
Saturday, January 13, 2024 9:30 PM EDT
Following this transaction, Frontline's fleet will consist of 84 vessels.
In this article: FRO
SaverOne: Publicly Traded Tech Startup With Highly Positively Skewed Risk-Reward Ratio
Article By:
Kate Hayden
Read
Tuesday, December 26, 2023 9:00 AM EDT
Bottom line, after a deep dive into the company we've determined that given SaverOne's valuation, the risk-reward opportunity is highly attractive.
In this article: SVRE
TalkMarkets Announces Company Spotlight Featuring SaverOne
Article By:
TalkMarkets Newswire
Read
Tuesday, December 19, 2023 9:46 AM EDT
TalkMarkets.com announces a company spotlight series featuring SaverOne (NASDAQ: SVRE), a startup company in the the self-driving EV space, with an attractive risk/reward ratio.
In this article: SVRE
Yum China’s Record-Breaking Third Quarter Sets New Highs For Net New Stores, Revenue And Adjusted Operating Profit
Article By:
Cents For Sense
Read
Monday, November 13, 2023 7:50 AM EDT
Yum China (YUMC), China’s largest restaurant operator, showed strong performance in the third quarter, setting new Q3 records for store openings, revenue and adjusted operating profit.
In this article: YUMC
Asian Stock: Tripod Technology Corp., Taiwan
Article By:
Andrew Stotz
Read
Monday, November 13, 2023 12:22 AM EDT
The company is maintaining average performance compared to 660 large Info Tech companies worldwide.
Akari Therapeutics' Nomacopan Is A Potential Blockbuster
Article By:
Shareholders Unite
Read
Thursday, November 9, 2023 9:50 AM EDT
Nomacopan, a complement dual wokring inhibitor, is a potential blockbuster with widespread use and already has an established safety profile.
In this article: AKTX
SaverOne Gains Rapid Traction With Its DDPS Solution
Article By:
Shareholders Unite
Read
Monday, November 6, 2023 10:51 AM EDT
SaverOne is an Israeli company offering safe driver products for cars and fleets that have a huge Total Addressable Market. The stock may be severly undervalued.
In this article: SVRE